In November 2018 Anti-Doping Norway (ADNO) has reported an anti-doping rule violation against the boxer after his sample tested positive for the prohibited substance Testosterone.
After notification a provisional suspension was ordered and the Athlete filed a statement in his defence.
The NIF Judging Committee settled the case based on the written submissions of the parties. In this case there were delays in the proceedings attributed to the Athlete since he repeatedly failed to respond timely to the ADNO communications nor provided additional evidence in his defence.
The Athlete denied the intentional use of Testosterone and stated that the substance was presecribed as medical treatment to improve his Testosterone levels. He provided to ADNO only a prescription of his foreign doctor abroad.
The NIF Judging Committee finds that the presence of a prohibited substance has been established in the Athlete’s sample and accordingly that he committed an anti-doping rule violation. The Athlete failed to demonstrate that the violation was not intentional nor that he had acted negligently.
Further the Committee considers that the Athlete had not applied for a TUE and only had provided insufficient medical information from his doctor whereas there was any evidence that showed that the Athlete suffered from low Testosterone levels.
Therefore the NIF Judging Committee decides on 22 May 2019 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 21 November 2018.
